The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Monday, December 09, 2019
Adastra announced that the FDA and the EMA have granted Orphan Drug Designation to zotiraciclib for the treatment of glioma.
read more
Thursday, December 12, 2019
Alkahest presented data this weekend from its phase 2a study, AKST6019-201, in mild-to-moderate Alzheimer’s Disease.
read more
Friday, December 20, 2019
Ionis announced Biogen has licensed IONIS-MAPTRx, an antisense therapy designed to selectively reduce production of MAPT in the central nervous system...
read more
Friday, December 20, 2019
Genmab and CureVac have entered into a research collaboration and license agreement.
read more
Tyme Technologies announced the first pancreatic cancer patient has been dosed in Part 2 of the TYME-88-Panc pivotal trial for the third-line ...
read more
Tuesday, January 14, 2020
Nurix announced a collaboration with Sanofi to discover, develop and commercialize a pipeline of targeted protein degradation drugs.
read more
Thursday, January 16, 2020
BioMarin announced the FDA and the MHRA have granted the Company IND and CTA for its gene therapy candidate BMN 307 to normalize blood Phe ...
read more
Thursday, January 23, 2020
Akcea and Ionis announced positive topline results from the Phase 2 study of AKCEA-APOCIII-LRx in the treatment of hypertriglyceridemia who are at ...
read more
Tuesday, January 28, 2020
Physicians and scientists at Rush University Medical Center found injecting tumors with influenza vaccines, including some FDA-approved seasonal flu ...
read more
Tuesday, February 04, 2020
Seqirus announced the FDA has approved AUDENZ Monovalent Vaccine to help protect individuals six months of age and older against influenza A (H5N1).
read more
Thursday, February 13, 2020
WPD announced its plan to initiate a Phase I clinical trial for Berubicin in pediatric brain cancer in Poland in collaboration with CNS.
read more
Wednesday, February 19, 2020
The FDA plays an essential role in overseeing our Nation’s medical products as part of our vital mission to protect and promote public health, ...
read more
Wednesday, February 26, 2020
CPhI Japan has announced the event will be postponed until a new date later in the year after consultation with key stakeholders and consideration of ...
read more
Immutep has announced the approval of its IND application by the FDA for eftilagimod alpha.
read more
Wednesday, March 11, 2020
International Pharmaceutical Expo (INTERPHEX) will be postponed due to the COVID-19 virus.
read more